Uncategorized
STAT+: An insider reveals the real goals of prior authorization
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.
Well, it appears the Associated Press chose violence with this grammar decision. Over my deadbody, AP. This debate has played out so many times, so do I dare ask you, loyal reader: Is it health care or healthcare? bob.herman@statnews.com.
‘The denial is the outcome’
Archelle Georgiou understands Americans’ frustrations with prior authorization. She helped squash the practice before, at what is now the country’s largest health insurance company.
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.
Well, it appears the Associated Press chose violence with this grammar decision. Over my deadbody, AP. This debate has played out so many times, so do I dare ask you, loyal reader: Is it health care or healthcare? bob.herman@statnews.com.
‘The denial is the outcome’
Archelle Georgiou understands Americans’ frustrations with prior authorization. She helped squash the practice before, at what is now the country’s largest health insurance company.
EnGene’s latest Phase 2 results on an experimental treatment for certain bladder cancer patients alarmed investors and raised concerns around the therapy’s future prospects.
The Canadian biotech’s shares {$ENGN} fell 80% Thursday morning after reporting …
Uncategorized
Angelini to buy Catalyst in $4B play for rare neuro drugs
The acquisition hands the Italian pharma a group of medicines approved to treat various CNS disorders and gives it wider market access in the U.S.
The acquisition hands the Italian pharma a group of medicines approved to treat various CNS disorders and gives it wider market access in the U.S.
Uncategorized
FDA reverses course on Atara, Pierre Fabre’s twice-rejected cell therapy after Prasad’s exit
The FDA turned away Ebvallo in January, taking issue with the design of the registrational trial. In a recent meeting, however, the agency agreed that the study could in fact support the cell therapy’s approval. The news comes a week after the departure of controversial biologics Director Vinay Prasad.
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
EnGene’s shares crash on updated pivotal bladder cancer data
Angelini to buy Catalyst in $4B play for rare neuro drugs
FDA reverses course on Atara, Pierre Fabre’s twice-rejected cell therapy after Prasad’s exit
STAT+: More political interference at the FDA?
Angelini inks $4.1B Catalyst buy to enter US rare disease market
Gilead wipes out most of Arcellx workforce
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Contributors9 years ago
The final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Uncategorized9 years ago
According to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years ago
Uber and Lyft are finally available in all of New York State
-
Uncategorized9 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years ago
The old and New Edition cast comes together to perform
-
Uncategorized9 years ago
Steph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years ago
Disney’s live-action Aladdin finally finds its stars